These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8228266)

  • 1. Preparation of CD8bright and CD8dim lymphocyte populations using two positive selection methods in tandem.
    Prince HE; Bermudez S; Plaeger-Marshall S
    J Immunol Methods; 1993 Oct; 165(2):139-48. PubMed ID: 8228266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of circulating CD4+ CD8+ lymphocytes in healthy individuals prompted by identification of a blood donor with a markedly elevated level of CD4+ CD8+ lymphocytes.
    Prince HE; Golding J; York J
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):597-605. PubMed ID: 8556507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.
    Scott CS; Richards SJ; Roberts BE
    Immunology; 1990 Jul; 70(3):351-6. PubMed ID: 2143170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes.
    Richards SJ; Jones RA; Roberts BE; Patel D; Scott CS
    Clin Exp Immunol; 1990 Jul; 81(1):149-55. PubMed ID: 1974177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomy of two CD8+ lymphocyte subsets in HIV infection. Depletion of CD8+ CD3- and expansion of CD8+ CD3+ subsets: consequence on the CD4/CD8 ratio.
    Mansour I; Doinel C; Rouger P
    Clin Exp Immunol; 1991 Sep; 85(3):481-4. PubMed ID: 1832598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of decay-accelerating factor and HLA-DR within the CD8-brightly positive population.
    Tomita A; Okada N; Okada H
    Eur J Immunol; 1991 Aug; 21(8):1843-8. PubMed ID: 1714392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of distinct subsets of CD8+ blood T cells through endothelial cell monolayers in vitro.
    Berman JS; Mahoney K; Saukkonen JJ; Masuyama J
    J Leukoc Biol; 1995 Sep; 58(3):317-24. PubMed ID: 7665987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of unconventional peripheral CD4+CD8dim T cell subsets.
    Lambert C; Ibrahim M; Iobagiu C; Genin C
    J Clin Immunol; 2005 Sep; 25(5):418-27. PubMed ID: 16160910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
    Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
    J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic switch from CD45RA+ to CD45RA- by normal blood T cells is associated with increased HLA-ABC expression for CD4+ and CD8+ populations but not for the NK-associated CD4-CD8dim+ or CD4-CD8- fractions.
    Jones RA; Richards SJ; Roberts BE; Child JA; Scott CS
    Immunology; 1990 May; 70(1):55-60. PubMed ID: 1972374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of phenotype and function of positively selected virus-specific CD8+ T lymphocytes following anti-Fab detachment from immunomagnetic beads.
    Geretti AM; Van Els CA; Van Baalen CA; Poelen MC; Osterhaus AD
    J Immunol Methods; 1993 May; 161(1):129-33. PubMed ID: 8486924
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoregulatory role of CD8alpha in the veto effect.
    Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
    Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and quantitative expression of the complement receptor type 1 (CR1) on human peripheral blood T lymphocytes.
    Yaskanin DD; Thompson LF; Waxman FJ
    Cell Immunol; 1992 Jun; 142(1):159-76. PubMed ID: 1534036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of immunomagnetic screening strategy for separation of CD4+ and CD8+ T cell subpopulations of peripheral blood].
    Feng MJ; Qiu C; Lai YJ; Chen CX; Li FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):205-9. PubMed ID: 15854277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells.
    Claus C; Schlaak J; Dittmayer M; Meyer zum Büschenfelde K; Dippold W
    Eur J Immunol; 1994 May; 24(5):1208-12. PubMed ID: 8181530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct large granular lymphocyte (LGL)/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression. The Yorkshire Leukaemia Group.
    Richards SJ; Sivakumaran M; Parapia LA; Balfour I; Norfolk DR; Kaeda J; Scott CS
    Br J Haematol; 1992 Nov; 82(3):494-501. PubMed ID: 1362495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls.
    Mazzoccoli G; Sothern RB; Parrella P; Muscarella LA; Fazio VM; Giuliani F; Polyakova V; Kvetnoy IM
    Clin Exp Med; 2012 Sep; 12(3):181-94. PubMed ID: 21910027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.